REGENXBIO (RGNX) SEC Filings & 10K Form

$16.04
+0.14 (+0.88%)
(As of 04/24/2024 ET)

Recent REGENXBIO SEC Filings

DateFilerForm TypeView
04/17/2024
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:11 PM
REGENXBIO (Filer)
Form DEF 14A
04/04/2024
3:15 PM
REGENXBIO (Filer)
Form DEFA14A
04/04/2024
3:20 PM
REGENXBIO (Filer)
Form ARS
03/21/2024
4:20 PM
REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
5:09 AM
REGENXBIO (Filer)
Form 424B5
03/07/2024
5:05 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:03 AM
REGENXBIO (Subject)
Form FWP
03/06/2024
3:23 PM
REGENXBIO (Filer)
Form 424B5
03/05/2024
3:26 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:28 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:13 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2024
2:04 PM
GIC Private Ltd (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:10 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:11 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
6:16 AM
REGENXBIO (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/18/2024
5:39 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:22 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:22 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:23 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:17 PM
REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:06 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
12:38 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:29 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
4:15 PM
Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G
11/08/2023
3:15 PM
REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/01/2023
3:42 PM
REGENXBIO (Filer)
Form 424B5
09/01/2023
3:12 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
3:31 PM
REGENXBIO (Filer)
Form S-3ASR
06/06/2023
4:11 PM
REGENXBIO (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:11 PM
Bennett Jean (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
Glucksmann Alexandra (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
MIGAUSKY GEORGE V (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
REGENXBIO (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:13 PM
REGENXBIO (Issuer)
Tasse Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:14 PM
Fox Allan M. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
8:49 AM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
Will this $2 AI stock double overnight? (Ad)

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>
05/03/2023
3:11 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RGNX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners